http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#head http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#assertion http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#assertion http://bio2rdf.org/drugbank:DB00872 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB01198 http://bio2rdf.org/drugbank:DB01198 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB01198 http://bio2rdf.org/drugbank_resource:DB00872_DB01198 http://purl.org/dc/terms/identifier drugbank_resource:DB00872_DB01198 http://bio2rdf.org/drugbank_resource:DB00872_DB01198 http://purl.org/dc/terms/title DDI between Conivaptan and Zopiclone - Conivaptan, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if conivaptan is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00872_DB01198 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00872_DB01198 http://www.w3.org/2000/01/rdf-schema#label DDI between Conivaptan and Zopiclone - Conivaptan, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if conivaptan is initiated, discontinued or dose changed. [drugbank_resource:DB00872_DB01198] http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#signature.MC0CFFBgOLv5nXZY http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#signature.MC0CFFBgOLv5nXZY http://purl.org/nanopub/x/hasSignature MC0CFFBgOLv5nXZYsebjDkfy4Yx0WbU5AhUAkbl7Mpj7mTg4jx6PrBCg6lPdM/Y= http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#signature.MC0CFFBgOLv5nXZY http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://purl.org/dc/terms/created 2018-03-30T11:12:58.590+02:00 http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E#signature.MC0CFFBgOLv5nXZY http://bio2rdf.org/drugbank_resource:DB00872_DB01198_nanopub.RAju0RnLnDBNH2HvIqu2Rn9sUJlu04ecofJIps8khPI5E http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234